HQ: Wadenswil, Zurich, Switzerland

Numab Contact Information – Key Personnel, Emails & Support Lines

numab.com

About Numab Company

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Numab Specialization

Pharmaceuticals, Biotechnology, Healthcare & Medical, Health Diagnostics, Hospitals & Clinics

Numab General Information

HQ: Wadenswil, Zurich, Switzerland

Business Type: Private

Employees: 51-100

Rounds: Series C

Founded Date: 2011

Number of Exits: 1

Company Type: For Profit

Operating Status: Active

Last Funding Type: Series C

Phone Number: 41445330471

Last Investment Activity: Feb 13, 2024

Investments Activity: Feb 13, 2024 Aug 8, 2023 Dec 5, 2022

Numab Email Format

{first_name}.{last_name}@numab.com — 50.0% (example: sarah.smith@domain.com)

{first_letter_first_name}.{last_name}@numab.com — 50.0% (example: s.smith@domain.com)

Numab General Numab Emails

  • General Inquiries

    info@numab.com

  • Admin Team

    admin@numab.com

  • Legal Department

    legal@numab.com

  • Unclassified inbox

    o.middendorp@numab.com

Contact details of 6 Numab executives

David Urech

CSO, and Co-CEO, Founder
  • Work email

    d*****h@numab.com

  • Personal email

    davidurech2174@gmail.com

Oliver Middendorp

Founder

Peter Lichtlen

Founder

Tea Gunde

Head of Pharmacology

Sebastian Meyer

Chief Operating Officer

Roland Helfenstein

Chief Financial Officer

Contact details of 1 Numab other employees

U003ed Urech

Job not specified
  • Work email

    u**********h@numab.com

Similar Companies like Numab

HQ: North Chicago, Illinois, United States

AbbVie

abbvie.com

AbbVie is a pharmaceutical company that discovers, develops,...

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 22, 2024

Founded Date: 2013

Number of Exits: 3

Company Type: For Profit

Stock Symbol: NYSE:ABBV

Operating Status: Active

HQ: New York, New York, United States

Pfizer is a biopharmaceutical company that provides affordab...

HQ: New York, New York, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Sep 3, 2024

Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture

Founded Date: 1849

Number of Exits: 19

Company Type: For Profit

Stock Symbol: NYSE:PFE

Operating Status: Active

Investor Type: Corporate Venture Capital, Venture Capital

HQ: Rahway, New Jersey, United States

Merck

merck.com

Merck is a biopharmaceutical company that offers medicines a...

HQ: Rahway, New Jersey, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Equity

Last Investment Activity: Mar 28, 2024

Founded Date: 1891

Number of Exits: 9

Company Type: For Profit

Stock Symbol: NYSE:MRK

Operating Status: Active


Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.